Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortMulti-kinase tablet for liver, kidney and thyroid cancers.Multi-kinase capsule for kidney cancer and GIST.
Body systemCancerCancer
Drug classTyrosine kinase inhibitorsTyrosine kinase inhibitors
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesHepatocellular (liver) cancer, Advanced kidney cancer, Differentiated thyroid cancerAdvanced kidney cancer, Gastrointestinal stromal tumour (GIST), Pancreatic neuroendocrine tumours
How it worksSlows tumour growth and blood supply.Slows tumour growth and blood supply.
Starts workingDepends on the cancer and regimenDepends on the cancer and regimen
Half-life25–48 hours40–60 hours (sunitinib); 80–110 hours (metabolite)
Typical adult doseDosed by your cancer team according to the treatment protocol.Dosed by your cancer team according to the treatment protocol.
FormsTabletCapsule
Common side effectsHand-foot skin reaction, Diarrhoea, High blood pressure, Rash, TirednessTiredness, Diarrhoea, High blood pressure, Mouth sores, Yellowing of skin, Hand-foot syndrome
Serious side effectsBleeding, Heart problems, Liver injury, Bowel perforationHeart failure, Liver failure, Underactive thyroid, Bleeding
Don't take ifPregnancy; Uncontrolled high blood pressurePregnancy; Uncontrolled high blood pressure; Severe liver impairment
AlcoholBest to limit. Alcohol may add to liver strain.Best to limit. Alcohol may add to liver strain.
PregnancyUsually avoidedAvoid.Usually avoidedAvoid.
BreastfeedingUsually avoidedAvoid.Usually avoidedAvoid.
In use since——
Brand namesUnited States: NexavarUnited Kingdom: NexavarIndia: Nexavar, Sorafenib (generic), SoranibUnited States: SutentUnited Kingdom: SutentIndia: Sutent, Sunitinib (generic), Sutinib
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC code—L01EX01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker